Here are five things to know:
1. The beneficiary of the exoskeleton system is a surgeon with a spinal cord injury.
2. The health plan initially refused coverage.
3. An independent review organization overturned the denial of coverage, after analyzing the beneficiary’s case and ReWalk clinical data.
4. The organization reported the ReWalk system was not an experimental technology, as it has clinically proven benefits to patients with spinal cord injuries.
5. With the exoskeleton, the beneficiary can stand up and walk.
More articles on devices:
Mesoblast cell therapy shows positive results for patients with rheumatoid arthritis — 5 points
Smith & Nephew target of a large growth in short interest — 4 observations
43 spine, orthopedic devices receive FDA 510(k) clearance in January
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
